We hypothesized that assessing DNI and MPC together in patients with suspected sepsis can provide a more robust and accurate diagnosis of sepsis and prognostic prediction than evaluating DNI or MPC alone, as well as other biomarkers, like CRP and procalcitonin. This evidence concerns the gene CRP and Sepsis.